NCT04523649View on ClinicalTrials.gov

Home-Based SolUtion for Remote Atrial Fibrillation Screening to PrevenT RecUrrence StrOke (HUA-TUO AF Trial)

NANot yet recruitingINTERVENTIONAL

Enrollment

1,740

Participants

Timeline

Start Date

June 1, 2022

Primary Completion Date

December 31, 2024

Study Completion Date

December 31, 2025

Conditions

Stroke, Cardiovascular

Interventions

DEVICE

Remote atrial fibrillation screening with handheld single lead ECG recorder

Patients in this group will be given a handheld single lead ECG recorder (Comfit Healthcare Devices Limited, Hong Kong SAR, China) and a patient-facing smartphone application specially designed for the study, and they will be requested to record daily ECG and certain vital measurement.

All Listed Sponsors

lead

The University of Hong Kong

OTHER

NCT04523649 - Home-Based SolUtion for Remote Atrial Fibrillation Screening to PrevenT RecUrrence StrOke (HUA-TUO AF Trial) | Biotech Hunter | Biotech Hunter